A federal judge in Texas has upheld the FDA’s decision to remove GLP-1 drugs, including Novo Nordisk’s Ozempic and Wegovy, from its drug shortage list, rejecting a bid by compounding pharmacies to ...
FORT LAUDERDALE — One of the designs that made the state’s crosswalk hit list no longer exists, prompting one city commissioner to question how the state is coming up with its running tally of ...
A group of compounding pharmacies has filed a lawsuit against the FDA, challenging the agency’s decision to remove semaglutide — which is used to treat Type 2 diabetes and obesity — from the drug ...
THE Commission on Elections (Comelec) backed proposals to scrap the limit on party-list seats in the House of Representatives, noting that the cap undermines representation of marginalized groups. “It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results